A new hotspot for cancer immunotherapy?
- PMID: 9815292
A new hotspot for cancer immunotherapy?
Comment on
-
Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.Cancer J Sci Am. 1998 Sep-Oct;4(5):316-23. Cancer J Sci Am. 1998. PMID: 9815296 Clinical Trial.